Antares Pharma PE Ratio 2006-2020 | ATRS

Current and historical p/e ratio for Antares Pharma (ATRS) from 2006 to 2020. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Antares Pharma PE ratio as of September 18, 2020 is 71.50.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Antares Pharma PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2020-09-18 2.86 71.50
2020-06-30 2.75 $0.04 68.75
2020-03-31 2.36 $0.02 118.00
2019-12-31 4.70 0 0.00
2019-09-30 3.35 $0.01 334.50
2019-06-30 3.29 $-0.01 0.00
2019-03-31 3.03 $-0.03 0.00
2018-12-31 2.72 $-0.04 0.00
2018-09-30 3.36 $-0.10 0.00
2018-06-30 2.58 $-0.12 0.00
2018-03-31 2.20 $-0.11 0.00
2017-12-31 1.99 $-0.10 0.00
2017-09-30 3.24 $-0.11 0.00
2017-06-30 3.22 $-0.12 0.00
2017-03-31 2.84 $-0.14 0.00
2016-12-31 2.33 $-0.16 0.00
2016-09-30 1.68 $-0.17 0.00
2016-06-30 1.05 $-0.17 0.00
2016-03-31 0.87 $-0.14 0.00
2015-12-31 1.21 $-0.14 0.00
2015-09-30 1.69 $-0.18 0.00
2015-06-30 2.08 $-0.19 0.00
2015-03-31 2.71 $-0.25 0.00
2014-12-31 2.57 $-0.27 0.00
2014-09-30 1.83 $-0.23 0.00
2014-06-30 2.67 $-0.23 0.00
2014-03-31 3.50 $-0.20 0.00
2013-12-31 4.47 $-0.16 0.00
2013-09-30 4.06 $-0.16 0.00
2013-06-30 4.16 $-0.14 0.00
2013-03-31 3.58 $-0.13 0.00
2012-12-31 3.81 $-0.10 0.00
2012-09-30 4.36 $-0.06 0.00
2012-06-30 3.63 $-0.04 0.00
2012-03-31 3.23 $-0.03 0.00
2011-12-31 2.20 $-0.05 0.00
2011-09-30 2.32 $-0.07 0.00
2011-06-30 2.21 $-0.08 0.00
2011-03-31 1.80 $-0.08 0.00
2010-12-31 1.70 $-0.08 0.00
2010-09-30 1.45 $-0.09 0.00
2010-06-30 1.76 $-0.11 0.00
2010-03-31 1.37 $-0.12 0.00
2009-12-31 1.14 $-0.14 0.00
2009-09-30 1.11 $-0.15 0.00
2009-06-30 0.89 $-0.16 0.00
2009-03-31 0.43 $-0.18 0.00
2008-12-31 0.37 $-0.19 0.00
2008-09-30 0.73 $-0.20 0.00
2008-06-30 0.72 $-0.19 0.00
2008-03-31 1.07 $-0.18 0.00
2007-12-31 0.98 $-0.14 0.00
2007-09-30 1.42 $-0.12 0.00
2007-06-30 1.58 $-0.12 0.00
2007-03-31 1.29 $-0.13 0.00
2006-12-31 1.20 $-0.17 0.00
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.475B $0.124B
Antares Pharma, Inc. develops, commercializes and markets novel delivery solutions, including needle-free and mini-needle injector systems, gel technologies and transdermal products, which improve both the efficiency of drug therapies and the quality of life for patients. The Company currently distributes its needle-free injector systems for the delivery of insulin and growth hormone in over 20 countries and an estradiol transdermal patch for hormone replacement therapy.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $67.221B 21.65
Align Technology (ALGN) United States $25.288B 14.93
McKesson (MCK) United States $24.674B 10.53
West Pharmaceutical Services (WST) United States $20.508B 71.76
AmerisourceBergen (ABC) United States $19.767B 12.71
Cooper (COO) United States $18.479B 35.42
Laboratory Of America Holdings (LH) United States $17.863B 17.14
Straumann Holding AG (SAUHF) Switzerland $16.384B 0.00
Cardinal Health (CAH) United States $13.944B 8.75
DENTSPLY SIRONA (XRAY) United States $10.123B 29.89
Henry Schein (HSIC) United States $8.705B 21.70
SmileDirectClub (SDC) United States $4.561B 0.00
STAAR Surgical (STAA) United States $2.563B 180.48
Merit Medical Systems (MMSI) United States $2.341B 30.80
Patterson (PDCO) United States $2.287B 14.65
CONMED (CNMD) United States $2.218B 39.61
Atrion (ATRI) United States $1.201B 34.66
Invacare (IVC) United States $0.253B 0.00
Retractable Technologies (RVP) United States $0.246B 39.26
Lifevantage (LFVN) United States $0.192B 15.74
Pro-Dex (PDEX) United States $0.110B 26.39
Milestone Scientific (MLSS) United States $0.090B 0.00
Biolase (BIOL) United States $0.028B 0.00